Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)

Capdevila, J; Fazio, N; Lopez, C; Teule, A; Valle, JW; Tafuto, S; Custodio, A; Reed, N; Raderer, M; Grande, E; Garcia-Carbonero, R; Jimenez-Fonseca, P; Hernando, J; Bongiovanni, A; Spada, F; Alonso, V; Antonuzzo, L; Spallanzani, A; Berruti, A; La Casta, A; Sevilla, I; Kump, P; Giuffrida, D; Merino, X; Trejo, L; Gajate, P; Matos, I; Lamarca, A; Ibrahim, T – 2021